Senior Manager

The approval was based on the petitioner's record of 5 peer-reviewed journal articles and 2 preprints in highly ranked journals. He demonstrated sustained acclaim through 54 citations, including a paper in the top 10% of its field, and 12 completed peer reviews for prestigious venues. Additionally, the petition showed major research funding and significant contributions to drug sensitivity prediction and robotic navigation.

The petition was approved based on a strong record of 7 peer-reviewed publications in top-tier venues like CVPR and ICCV, alongside 286 citations. The petitioner met the O-1A criteria through extensive peer review invitations for journals like IEEE T-PAMI and leadership roles in industry-standard benchmarking challenges. Evidence of international research funding from the European Research Council further solidified the claim of extraordinary ability.

The petition was approved based on the petitioner's documented extraordinary ability in AI, supported by peer-reviewed publications and three patent applications. Evidence of 30 citations from independent researchers worldwide demonstrated the international reach and adoption of his findings. Additionally, his critical role as a CEO and his peer-review activity satisfied the O-1A criteria.

Approval was based on the petitioner's extensive record of peer-reviewed conference papers and journal articles that garnered high citations from international researchers. He demonstrated extraordinary ability through his regular invitations to conduct peer reviews for authoritative journals and conferences. His work's practical applications in health databases and economical utility spending further satisfied the O-1 criteria.